Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 5:200-206 (2008)
© 2008 The American Thoracic Society
doi: 10.1513/pats.200708-143MG

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Golbin, J. M.
Right arrow Articles by Caples, S. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Golbin, J. M.
Right arrow Articles by Caples, S. M.

Obstructive Sleep Apnea, Cardiovascular Disease, and Pulmonary Hypertension

Jason M. Golbin1, Virend K. Somers2,3 and Sean M. Caples1

Divisions of 1 Pulmonary and Critical Care Medicine, 2 Cardiovascular Diseases, and 3 Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota

Correspondence and requests for reprints should be addressed to Sean M. Caples, D.O., Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. E-mail: caples.sean{at}mayo.edu

ABSTRACT

With the growing epidemic of obesity in an aging population, obstructive sleep apnea (OSA) is increasingly encountered in clinical practice. Given the acute cardiopulmonary stressors consequent to repetitive upper airway collapse, as well as evidence for cardiovascular homeostatic dysregulation in subjects with sleep apnea, there is ample biologic plausibility that OSA imparts increased cardiovascular risk, independent of comorbid disease. Indeed, observational studies have suggested strong associations with multiple disorders, such as systemic hypertension, heart failure, cardiac arrhythmias, and pulmonary hypertension. Further data in the form of longitudinal cohort studies and randomized controlled trials are accruing to add to the body of evidence. This review examines pathophysiologic mechanisms and explores current concepts regarding the impact of OSA and its treatment on selected clinical disease states.

Key Words: sleep-disordered breathing • positive airway pressure • arrhythmia • stroke




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
E. Tasali and M. S. M. Ip
Obstructive Sleep Apnea and Metabolic Syndrome: Alterations in Glucose Metabolism and Inflammation
Proceedings of the ATS, February 15, 2008; 5(2): 207 - 217.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Thoracic Society.